Mechanism of tandem duplication formation in BRCA1-mutant cells

Nicholas A Willis1, Richard L Frock2, Francesca Menghi3

  • 1Department of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.

Nature
|November 24, 2017
PubMed

Insights

BRCA1 deficiency drives the formation of ~10 kilobase tandem duplications by preventing replication fork restart. This tandem duplicator phenotype is a signature of BRCA1-deficient cancers, including breast and ovarian cancers.

Area of Science:

  • Genetics and Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • Microhomology-mediated tandem duplications (MDTs) are prevalent in BRCA1-linked breast cancer.
  • The precise mechanism driving this genomic instability in BRCA1-deficient cancers remains unclear.
  • BRCA1 and BRCA2 proteins play critical roles in DNA repair and genome maintenance.

Purpose of the Study:

  • To elucidate the mechanism underlying the formation of ~10 kilobase tandem duplications associated with BRCA1 deficiency.
  • To investigate the role of BRCA1 and BRCA2 in suppressing tandem duplications at replication fork barriers.
  • To determine if this tandem duplicator phenotype is a general signature of BRCA1-deficient cancers.

Main Methods:

  • Utilized primary mammalian cells to study tandem duplication formation at a site-specific replication fork barrier (Tus-Ter system).
  • Compared the roles of BRCA1 and BRCA2 in suppressing tandem duplications.
  • Investigated the mechanisms of replication restart, bypass, and DNA end joining in BRCA1-mutant cells.
  • Analyzed the association of ~10 kilobase tandem duplications with BRCA1 inactivation in ovarian cancer.

Main Results:

  • BRCA1, but not BRCA2, suppresses tandem duplications at stalled replication forks created by Tus-Ter binding.
  • Tandem duplications in BRCA1-mutant cells arise from replication restart-bypass mechanisms, involving end joining or microhomology-mediated template switching.
  • Solitary DNA ends at Tus-Ter sites suggest misrepair contributes to tandem duplication formation.
  • BRCA1 inactivation is strongly linked to ~10 kilobase tandem duplications in ovarian cancer.

Conclusions:

  • BRCA1 deficiency leads to a tandem duplicator phenotype specifically at stalled replication forks.
  • The mechanism involves impaired replication restart and subsequent DNA repair events.
  • This tandem duplicator phenotype is a potential pan-cancer biomarker for BRCA1 deficiency, extending beyond breast to ovarian cancer.

Related Concept Videos

Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
6.4K
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
15.1K
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

4.5K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
63.8K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.2K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.2K